These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8988338)

  • 21. Production of tissue inhibitor of metalloproteinases 3 is selectively enhanced by calcium pentosan polysulfate in human rheumatoid synovial fibroblasts.
    Takizawa M; Ohuchi E; Yamanaka H; Nakamura H; Ikeda E; Ghosh P; Okada Y
    Arthritis Rheum; 2000 Apr; 43(4):812-20. PubMed ID: 10765925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-4 inhibits prostaglandin E2 production by freshly prepared adherent rheumatoid synovial cells via inhibition of biosynthesis and gene expression of cyclo-oxygenase II but not of cyclo-oxygenase I.
    Sugiyama E; Taki H; Kuroda A; Mino T; Yamashita N; Kobayashi M
    Ann Rheum Dis; 1996 Jun; 55(6):375-82. PubMed ID: 8694577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts.
    Petrow PK; Hummel KM; Schedel J; Franz JK; Klein CL; Müller-Ladner U; Kriegsmann J; Chang PL; Prince CW; Gay RE; Gay S
    Arthritis Rheum; 2000 Jul; 43(7):1597-605. PubMed ID: 10902765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
    Andreakos E; Smith C; Kiriakidis S; Monaco C; de Martin R; Brennan FM; Paleolog E; Feldmann M; Foxwell BM
    Arthritis Rheum; 2003 Jul; 48(7):1901-12. PubMed ID: 12847684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of histamine on the production of matrix metalloproteinases-1, -3, -8 and -13, and TNFalpha and PGE(2) by human articular chondrocytes and synovial fibroblasts in vitro: a comparative study.
    Tetlow LC; Woolley DE
    Virchows Arch; 2004 Nov; 445(5):485-90. PubMed ID: 15378360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of heparinoid on the production of tissue inhibitor of metalloproteinases (TIMP)-3 in rheumatoid synovial fibroblasts.
    Watanabe H; Wada H; Itoh M; Kataoka M; Kido H; Naruse T
    J Pharm Pharmacol; 2002 May; 54(5):699-705. PubMed ID: 12005365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38.
    Hiramitsu T; Yasuda T; Ito H; Shimizu M; Julovi SM; Kakinuma T; Akiyoshi M; Yoshida M; Nakamura T
    Rheumatology (Oxford); 2006 Jul; 45(7):824-32. PubMed ID: 16449361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A major metabolite of aceclofenac, 4'-hydroxy aceclofenac, suppresses the production of interstitial pro-collagenase/proMMP-1 and pro-stromelysin-1/proMMP-3 by human rheumatoid synovial cells.
    Yamazaki R; Kawai S; Mizushima Y; Matsuzaki T; Hashimoto S; Yokokura T; Ito A
    Inflamm Res; 2000 Mar; 49(3):133-8. PubMed ID: 10807502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts.
    Hong KH; Cho ML; Min SY; Shin YJ; Yoo SA; Choi JJ; Kim WU; Song SW; Cho CS
    Clin Exp Immunol; 2007 Mar; 147(3):573-9. PubMed ID: 17302909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triptolide, a novel diterpenoid triepoxide from Tripterygium wilfordii Hook. f., suppresses the production and gene expression of pro-matrix metalloproteinases 1 and 3 and augments those of tissue inhibitors of metalloproteinases 1 and 2 in human synovial fibroblasts.
    Lin N; Sato T; Ito A
    Arthritis Rheum; 2001 Sep; 44(9):2193-200. PubMed ID: 11592385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts.
    Ito A; Itoh Y; Sasaguri Y; Morimatsu M; Mori Y
    Arthritis Rheum; 1992 Oct; 35(10):1197-201. PubMed ID: 1418006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone Methylation and STAT-3 Differentially Regulate Interleukin-6-Induced Matrix Metalloproteinase Gene Activation in Rheumatoid Arthritis Synovial Fibroblasts.
    Araki Y; Tsuzuki Wada T; Aizaki Y; Sato K; Yokota K; Fujimoto K; Kim YT; Oda H; Kurokawa R; Mimura T
    Arthritis Rheumatol; 2016 May; 68(5):1111-23. PubMed ID: 26713842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of the terminal complement components C5b-9 with synovial fibroblasts: binding to the membrane surface leads to increased levels in collagenase-specific mRNA.
    Jahn B; Von Kempis J; Krämer KL; Filsinger S; Hänsch GM
    Immunology; 1993 Feb; 78(2):329-34. PubMed ID: 8473021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts.
    Migita K; Kawabe Y; Tominaga M; Origuchi T; Aoyagi T; Eguchi K
    Lab Invest; 1998 May; 78(5):535-9. PubMed ID: 9605178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis.
    Tomita T; Nakase T; Kaneko M; Shi K; Takahi K; Ochi T; Yoshikawa H
    Arthritis Rheum; 2002 Feb; 46(2):373-8. PubMed ID: 11840439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo.
    Tetlow LC; Lees M; Ogata Y; Nagase H; Woolley DE
    Rheumatol Int; 1993; 13(2):53-9. PubMed ID: 8356391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis.
    Wernicke D; Seyfert C; Hinzmann B; Gromnica-Ihle E
    J Rheumatol; 1996 Apr; 23(4):590-5. PubMed ID: 8730110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis.
    van Lent PL; Span PN; Sloetjes AW; Radstake TR; van Lieshout AW; Heuvel JJ; Sweep CG; van den Berg WB
    Ann Rheum Dis; 2005 Mar; 64(3):368-74. PubMed ID: 15485996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of actarit on synovial cell functions in patients with rheumatoid arthritis.
    Takeba Y; Suzuki N; Wakisaka S; Nagafuchi H; Mihara S; Kaneko A; Asai T; Sakane T
    J Rheumatol; 1999 Jan; 26(1):25-33. PubMed ID: 9918236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential in vivo expression of collagenase messenger RNA in synovium and cartilage. Quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis.
    Wolfe GC; MacNaul KL; Buechel FF; McDonnell J; Hoerrner LA; Lark MW; Moore VL; Hutchinson NI
    Arthritis Rheum; 1993 Nov; 36(11):1540-7. PubMed ID: 8240430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.